Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases
申请人:Cenix Bioscience GmbH
公开号:EP1832283A1
公开(公告)日:2007-09-12
The present invention relates to the use of inhibitors of scavenger receptor class proteins, in particular ScarB1 for the production of a medicament for treatment of and/or prophylaxis against infections, involving liver cells and/or hematopoietic cells, in particular malaria.
本发明涉及使用清道夫受体类蛋白,特别是 ScarB1 的抑制剂来生产治疗和/或预防涉及肝细胞和/或造血细胞,特别是疟疾的感染的药物。